Read + Share
Amedeo Smart
Independent Medical Education
Kumar EA, Korfi K, Bewicke-Copley F, Close K, et al. CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma. Br J Haematol 2024 Aug 26. doi: 10.1111/bjh.19671.PMID: 39188028
Email
LinkedIn
Privacy Policy